AI Chatbot for Young Adult Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This clinical trial studies whether an artificial intelligence (AI)-powered supportive care chatbot is helpful for addressing the supportive care needs of young adult cancer survivors. Young adult cancer survivors often experience ongoing and distressing symptoms following treatment, including extreme tiredness and lack of energy, anxiety, and difficulty sleeping. Young adult cancer survivors report a variety of strategies to self-manage these symptoms; however, there remains a gap in targeted interventions focused on the needs in young adult survivors. The AI-powered supportive care chatbot is designed to provide evidence-based information on supportive care for young adult cancer survivors. Users interact with the chatbot by entering free-text questions or selecting from predefined topics to receive tailored educational responses related to supportive care across the cancer continuum, including treatment effects, symptom management, care transitions, and life after cancer. The AI-powered supportive care chatbot may be an effective way to help address the supportive care needs of young adult cancer survivors.
Who Is on the Research Team?
Robert Knoerl
Principal Investigator
University of Michigan Rogel Cancer Center
Are You a Good Fit for This Trial?
This trial is for young adults who have survived cancer. Participants should be interested in using a digital tool to help manage ongoing symptoms and supportive care needs after their cancer treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants interact with the AI-powered supportive care chatbot in a self-directed manner
Optional Extension
Participants may choose to continue using the chatbot for an additional 8 weeks
Follow-up
Participants are monitored for outcomes such as acceptability, usability, and retention
What Are the Treatments Tested in This Trial?
Interventions
- Artificial Intelligence-powered Supportive Care Chatbot
Trial Overview
The study is testing an AI-powered chatbot designed to give personalized information and support about managing symptoms, side effects, and life after cancer. Participants will interact with the chatbot, complete surveys, and may take part in interviews.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Patients interact with AI-powered supportive care chatbot in a self-directed manner for 4 weeks. Following the initial 4-week use period, patients choose to either continue to use the chatbot for an additional 8 weeks or conclude study participation.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan Rogel Cancer Center
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.